Provectus Biopharmaceuticals, Inc. (OTCMKTS:PVCT – Get Free Report) saw a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 3,800 shares, a decline of 93.5% from the September 30th total of 58,700 shares. Based on an average daily trading volume, of 144,400 shares, the days-to-cover ratio is currently 0.0 days.
Provectus Biopharmaceuticals Stock Up 0.8 %
Shares of PVCT stock traded up $0.00 during midday trading on Friday, reaching $0.11. 103,971 shares of the stock were exchanged, compared to its average volume of 248,030. The company’s 50 day moving average is $0.10 and its two-hundred day moving average is $0.13. Provectus Biopharmaceuticals has a 1 year low of $0.04 and a 1 year high of $0.22.
Provectus Biopharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Provectus Biopharmaceuticals
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Roadhouse Stock Steering for New Highs This Year
- What Are Trending Stocks? Trending Stocks Explained
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Compound Interest and Why It Matters When Investing
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Provectus Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provectus Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.